News

Ithaca Energy Plc to boost Cygnus stake to 85% in £116m deal

Ithaca Energy Plc has secured a significant deal to acquire an additional 46.25% stake in the Cygnus gas field, enhancing its production and portfolio strategy...

Greggs Plc sees sales rise 7.4%, outlook unchanged

Greggs Plc (LON:GRG) reports strong trading results for early 2025, with sales rising 7.4% and ongoing expansion plans, as year-end expectations remain stable...

LondonMetric Property Plc reports strong earnings and dividend growth

LondonMetric Property Plc (LON:LMP) reports impressive full-year results for FY 2025, showcasing record net rental income and earnings, driven by strategic growth in logistics...

AstraZeneca Plc acquires EsoBiotec in $1bn cell therapy deal

AstraZeneca has successfully acquired EsoBiotec, enhancing its cancer therapy capabilities with innovative in vivo cell therapies that promise faster treatment access...

Cerillion Plc: Eurasian Expansion and Big Deals Drive 2025 Growth Outlook (Video)

With a significant £8 million contract extension in Europe and a landmark $11 million deal with a national telco in Armenia, Cerillion is doubling down on high-value markets...

Vodafone Group Plc launches €500m Share Buyback

Vodafone Group Plc announces a €500 million share repurchase program aimed at reducing share capital, set to commence on May 20, 2025...

Warpaint London posts 2024 Annual Report and AGM Notice

Warpaint London plc (LON:W7L) announces the release of its 2024 Annual Report and details for the upcoming AGM on June 17, 2025...

Poolbeg Pharma launches £4.1m fundraising

Poolbeg Pharma plc (LON:POLB) announces a conditional fundraising aimed at raising £4.1 million to drive innovative pharmaceutical developments and address unmet medical needs...

Renold declares 3p interim preference dividend

Renold Plc (LON:RNO) announces a half-yearly preference dividend of 3 pence per unit for its 6% cumulative stock, payable on July 1, 2025...

Cizzle Biotechnology raises £150k to support cancer test rollout

Cizzle Biotechnology Holdings Plc has raised £150,000 to advance its CIZ1B early cancer test, enhancing access to innovative diagnostics in the UK and Europe...

Hercules Site Services changes name to Hercules Plc, effective immediately

Hercules Site Services Plc has officially rebranded to Hercules Plc, effective May 2025, signaling a new era for the UK infrastructure and construction sectors...

Poolbeg Pharma advances in POLB 001 and GLP-1 trials

Poolbeg Pharma Plc has released its audited results for 2024, highlighting significant advancements in cancer immunotherapy, including the promising POLB 001 therapy...

CyanConnode secures $7.5m convertible loan

CyanConnode secures a $7.5 million loan agreement to boost its smart metering initiatives, enhancing growth opportunities in India and beyond...

Navigating the future of maritime decarbonisation

Explore the latest insights on maritime decarbonisation, focusing on scrubbers and e-fuels, pivotal for investors seeking sustainable shipping solutions...

Why 3D thruster flow modelling outperforms 2D methods

RYDER's study highlights the need for 3D CFD in offshore engineering, revealing how it surpasses 2D models in accurately assessing thruster-seabed interactions...

Nanoco’s legal offensive signals strategic IP mastery

Nanoco Group's patent infringement lawsuit against LG Electronics highlights its strategic IP management, reinforcing its position in the competitive tech industry...

Why digital assets and RegTech are driving insolvency innovation in 2025

In 2025, the insolvency protection sector is evolving with digital assets and RegTech, reshaping practices and investment strategies for a modern landscape...

Scotland’s AI powerhouse driving healthtech growth

Scotland emerges as a leader in AI and healthcare innovation, driven by a blend of research excellence and ethical practices, solidifying Edinburgh's top position in the UK...

Investors eye the untapped potential of white hydrogen

The discovery of vast natural hydrogen reserves, or "white hydrogen," is transforming the energy sector, offering a low-cost, sustainable alternative to fossil fuels...

Poolbeg Pharma targets severe flu and cytokine storms

Poolbeg Pharma's POLB 001 is an innovative, orally-administered treatment aiming to combat severe influenza and cytokine release syndrome, revolutionising immunotherapy...
Search

Funds

CNA

Ithaca Energy Plc to boost Cygnus stake to 85% in £116m deal

Ithaca Energy Plc has secured a significant deal to acquire an additional 46.25% stake in the Cygnus gas field, enhancing its production and portfolio strategy...

Greggs Plc sees sales rise 7.4%, outlook unchanged

Greggs Plc (LON:GRG) reports strong trading results for early 2025, with sales rising 7.4% and ongoing expansion plans, as year-end expectations remain stable...

LondonMetric Property Plc reports strong earnings and dividend growth

LondonMetric Property Plc (LON:LMP) reports impressive full-year results for FY 2025, showcasing record net rental income and earnings, driven by strategic growth in logistics...

AstraZeneca Plc acquires EsoBiotec in $1bn cell therapy deal

AstraZeneca has successfully acquired EsoBiotec, enhancing its cancer therapy capabilities with innovative in vivo cell therapies that promise faster treatment access...

Cerillion Plc: Eurasian Expansion and Big Deals Drive 2025 Growth Outlook (Video)

With a significant £8 million contract extension in Europe and a landmark $11 million deal with a national telco in Armenia, Cerillion is doubling down on high-value markets...

Vodafone Group Plc launches €500m Share Buyback

Vodafone Group Plc announces a €500 million share repurchase program aimed at reducing share capital, set to commence on May 20, 2025...

Warpaint London posts 2024 Annual Report and AGM Notice

Warpaint London plc (LON:W7L) announces the release of its 2024 Annual Report and details for the upcoming AGM on June 17, 2025...

Poolbeg Pharma launches £4.1m fundraising

Poolbeg Pharma plc (LON:POLB) announces a conditional fundraising aimed at raising £4.1 million to drive innovative pharmaceutical developments and address unmet medical needs...

Renold declares 3p interim preference dividend

Renold Plc (LON:RNO) announces a half-yearly preference dividend of 3 pence per unit for its 6% cumulative stock, payable on July 1, 2025...

Cizzle Biotechnology raises £150k to support cancer test rollout

Cizzle Biotechnology Holdings Plc has raised £150,000 to advance its CIZ1B early cancer test, enhancing access to innovative diagnostics in the UK and Europe...

Hercules Site Services changes name to Hercules Plc, effective immediately

Hercules Site Services Plc has officially rebranded to Hercules Plc, effective May 2025, signaling a new era for the UK infrastructure and construction sectors...

Poolbeg Pharma advances in POLB 001 and GLP-1 trials

Poolbeg Pharma Plc has released its audited results for 2024, highlighting significant advancements in cancer immunotherapy, including the promising POLB 001 therapy...

CyanConnode secures $7.5m convertible loan

CyanConnode secures a $7.5 million loan agreement to boost its smart metering initiatives, enhancing growth opportunities in India and beyond...

Navigating the future of maritime decarbonisation

Explore the latest insights on maritime decarbonisation, focusing on scrubbers and e-fuels, pivotal for investors seeking sustainable shipping solutions...

Why 3D thruster flow modelling outperforms 2D methods

RYDER's study highlights the need for 3D CFD in offshore engineering, revealing how it surpasses 2D models in accurately assessing thruster-seabed interactions...

Nanoco’s legal offensive signals strategic IP mastery

Nanoco Group's patent infringement lawsuit against LG Electronics highlights its strategic IP management, reinforcing its position in the competitive tech industry...

Why digital assets and RegTech are driving insolvency innovation in 2025

In 2025, the insolvency protection sector is evolving with digital assets and RegTech, reshaping practices and investment strategies for a modern landscape...

Scotland’s AI powerhouse driving healthtech growth

Scotland emerges as a leader in AI and healthcare innovation, driven by a blend of research excellence and ethical practices, solidifying Edinburgh's top position in the UK...

Investors eye the untapped potential of white hydrogen

The discovery of vast natural hydrogen reserves, or "white hydrogen," is transforming the energy sector, offering a low-cost, sustainable alternative to fossil fuels...

Poolbeg Pharma targets severe flu and cytokine storms

Poolbeg Pharma's POLB 001 is an innovative, orally-administered treatment aiming to combat severe influenza and cytokine release syndrome, revolutionising immunotherapy...
Search

Funds

News

FTSE 100

Funds